4//SEC Filing
Palti Yoram 4
Accession 0001209191-18-048680
CIK 0001645113other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 4:22 PM ET
Size
7.7 KB
Accession
0001209191-18-048680
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Palti Yoram
DirectorChief Technology Officer
Transactions
- Sale
Ordinary Shares
2018-08-27$40.05/sh−13,450$538,663→ 1,045,388 total(indirect: Bennett Limited) - Sale
Ordinary Shares
2018-08-24$40.00/sh−12,216$488,645→ 1,058,838 total(indirect: Bennett Limited)
Footnotes (3)
- [F1]On August 24, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 12,216 shares in multiple trades at prices ranging from $40.00 to $40.05. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Professor Palti shares voting and investment power for the shares held by Bennett Limited.
- [F3]On August 27, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Bennett Limited, Bennett Limited sold 13,450 shares in multiple trades at prices ranging from $40.00 to $40.35. The price reported above reflects the weighted average sale price. Bennett Limited hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001654403
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 4:22 PM ET
- Size
- 7.7 KB